Worldwide: Broad's CRISPR/Cas9 Patent EP2771468 Revoked By The European Patent Office - DLA Piper

In the ongoing CRISPR patent battle, after four days of oral arguments, it was announced today that the European Patent Office's (EPO) Technical Board of Appeal (Board)